And we are back with another edition of the Federalist Radio Hour.

I'm Matt Kittle, Senior Elections correspondent at at the Federalist and your experience Sherpa on today's quest for knowledge.

As always, you can email the show at Radio at the Federalist.com. Follow us on X at FDRLST. Make sure to subscribe wherever you download your podcast and, of course, to the premium version

of our website as well. Our guest today is Ryan Anderson, president of the Ethics and Public

Policy Center. EPPC's new eye-opening study found a shocking 11% of women suffer at least one serious adverse effect within 45 days

of taking the abortion pill known as Mithpristone for an abortion. Ryan, thank you so much

for being here on this very important topic. Thanks for having me. It's a pleasure to be with you. And you're exactly right. This is a vitally important topic. And so I'm very glad to get to discuss it with you for the Federalist audience.

Yeah. I don't know of anything more important when we're talking about the foundation of this great republic, life comes first in the whole

notion of life, liberty, and the pursuit of happiness. This was from my colleague,

Jordan Boyd, excellent reporter here at the Federalist and producer of this fine show, the Federalist

Radio Hour, noting this study,

abortion advocates, their allies in the corporate media, and even the U.S. Food and Drug

Administration insists the pill responsible for more than half of the nation's abortions, is safe

and effective. The new wide-ranging analysis of insurance claims regarding

the abortion drug regimen, however, found that the rate of life-threatening complications

due to this wonder drug, so-called, was 22 times higher than that, what the FDA and the drugs manufacturers suggest.

That is shocking, to save the least.

Tell us how this study came about and what you looked at.

Sure.

So, you know, as your listeners know, all of our data is for sale, whether it's our smartphone

data, our GPS data, our internet browsing, or our health insurance data.

And so we were able to get access to an all-payer insurance claims database from 2017 to

...